Walker Neal Insider Trades

Insider Trading History

Track insider trading activity for Walker Neal. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Aldeyra Therapeutics
Aldeyra Therapeutics ALDX
Director
Holding Value $135k 70,000 shares
Last Trade
Jun 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$126k 73,318 shares
$1.72
$1.93
Aclaris Therapeutics
Aclaris Therapeutics ACRS
CEO
Holding Value $1.03M 190,425 shares
Last Trade
Feb 03, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$229k 63,475 shares
$3.60
$5.43
Aclaris Therapeutics
Aclaris Therapeutics ACRS
CEO
Holding Value $8.48M 1,562,497 shares
Last Trade
Feb 03, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$229k 63,475 shares
$3.60
$5.43
Aclaris Therapeutics
Aclaris Therapeutics ACRS
CEO
Holding Value $8.38M 1,543,886 shares
Last Trade
Feb 03, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$64.6k 18,611 shares
$3.47
$5.43
Aclaris Therapeutics
Aclaris Therapeutics ACRS
CEO
Holding Value $5.22M 961,700 shares
Last Trade
Feb 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.46M 1,236,500 shares
$3.60
$5.43
Aclaris Therapeutics
Aclaris Therapeutics ACRS
CEO
Holding Value $8.14M 1,499,022 shares
Last Trade
Jan 02, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$28.7k 9,952 shares
$2.88
$5.43
Aclaris Therapeutics
Aclaris Therapeutics ACRS
CEO
Holding Value $8.19M 1,508,974 shares
Last Trade
Jan 02, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$84k 29,150 shares
$2.88
$5.43
Aclaris Therapeutics
Aclaris Therapeutics ACRS
CEO
Holding Value $163k 30,034 shares
Last Trade
Jan 02, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$84k 29,150 shares
$2.88
$5.43
Aldeyra Therapeutics
Aldeyra Therapeutics ALDX
Director
Holding Value $121k 62,728 shares
Last Trade
Jun 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$175k 65,141 shares
$2.69
$1.93
Aclaris Therapeutics
Aclaris Therapeutics ACRS
CEO
Holding Value $0 0 shares
Last Trade
May 01, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$13.1k 9,467 shares
$1.38
$5.43
Aclaris Therapeutics
Aclaris Therapeutics ACRS
CEO
Holding Value $8.05M 1,482,799 shares
Last Trade
May 01, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$13.1k 9,467 shares
$1.38
$5.43
Aclaris Therapeutics
Aclaris Therapeutics ACRS
CEO
Holding Value $8.04M 1,479,824 shares
Last Trade
May 01, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$4.11k 2,975 shares
$1.38
$5.43
Aclaris Therapeutics
Aclaris Therapeutics ACRS
CEO
Holding Value $8.02M 1,476,374 shares
Last Trade
Apr 01, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$14k 9,467 shares
$1.48
$5.43
Aclaris Therapeutics
Aclaris Therapeutics ACRS
CEO
Holding Value $8M 1,473,332 shares
Last Trade
Apr 01, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$4.5k 3,042 shares
$1.48
$5.43
Aclaris Therapeutics
Aclaris Therapeutics ACRS
CEO
Holding Value $51.4k 9,467 shares
Last Trade
Apr 01, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$14k 9,467 shares
$1.48
$5.43
Aclaris Therapeutics
Aclaris Therapeutics ACRS
CEO
Holding Value $7.98M 1,470,184 shares
Last Trade
Mar 01, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$18.8k 9,466 shares
$1.99
$5.43
Aclaris Therapeutics
Aclaris Therapeutics ACRS
CEO
Holding Value $103k 18,934 shares
Last Trade
Mar 01, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$18.8k 9,466 shares
$1.99
$5.43
Aclaris Therapeutics
Aclaris Therapeutics ACRS
CEO
Holding Value $7.97M 1,466,907 shares
Last Trade
Mar 01, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$6.52k 3,277 shares
$1.99
$5.43
Aclaris Therapeutics
Aclaris Therapeutics ACRS
INTERIM CEO
Holding Value $4.83M 888,800 shares
Last Trade
Feb 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.13M 888,800 shares
$2.40
$5.43
Aclaris Therapeutics
Aclaris Therapeutics ACRS
INTERIM CEO
Holding Value $7.93M 1,460,718 shares
Last Trade
Feb 01, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$8.83k 3,559 shares
$2.48
$5.43

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up